We recently compiled a list of the 10 Best Penny Stocks Under $1 According to Hedge Funds.
Medicus Pharma Ltd. (NASDAQ:MDCXW) is one of the best penny stocks on this list
TheFly reported on May 14 that MDCXW announced its financial results for the three months ended March 31, 2026, along with a detailed corporate update across its development programs. The corporation reported progress in its Teverelix program, including FDA clearance to proceed with a Phase 2b dose-optimization study in advanced prostate cancer and submission of additional protocols targeting urinary retention in benign prostatic hyperplasia. The company’s strategic updates included expanded financing capacity through ATM arrangements and continued evaluation of partnerships and acquisitions.
Financial results showed cash and cash equivalents of $6.4 million, operating expenses of $8.6 million, and a net loss of $9.0 million, alongside higher R&D spending. The company reiterated ongoing capital access and multiple anticipated clinical milestones for 2026. Other than that, earlier on May 6, Medicus Pharma Ltd. (NASDAQ:MDCXW) reported updated findings from an expanded Phase 2 SKNJCT-003 analysis evaluating a doxorubicin microneedle array for nodular basal cell carcinoma.